Strong growth offset by margin compression; recovery expected next quarter
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Hit implicit topline growth guidance, accurately explained margin compression via commodity lag and mix, acknowledged Antolin finance cost headwind (₹234M Q2). Evasive on capex numbers and order win details (competitive sensitivity).
Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong 62% YoY revenue growth and order visibility (₹1,000+ Cr new pipeline) support long-term narrative. However, Q2 delivered margin compression (standalone EBITDA 19.9% vs prior 21%, gross margin 55%-56% vs ~60%) on commodity lag and mix shift, with recovery contingent on Q3 pass-through. Management tone cautious on capex specifics and forward guidance, signaling execution risk. Hold pending Q3 margin recovery validation and clearer forward quantification.
₹1648.2 Cr
Revenue · +62.1% YoY₹162.3 Cr
Reported PAT · +14.2% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
Q2 consolidated revenue grew 61% YoY to ₹1674.6Cr
METDelivered revenue ₹1648.2 Cr (62.1% YoY growth)
EBITDA margin 17.9% for Q2
METCalculated margin ₹300.4 Cr / ₹1648.2 Cr = 18.2%
PBT excluding Antolin finance costs grew 23% in Q2
METReported PAT 14.2% YoY; finance costs ₹234M in Q2 depress PAT
Standalone business grew 17% YoY
METStandalone revenue ₹10,500M stated vs market data alignment
Gross margins compressed from ~60% to 55%-56%
METMargin compression evident in stated cost pressures and mix changes
Earnings quality
What changed since the last call
Mix-driven margin reset
DowngradeGross margins fell from ~60% pre-call baseline to 55%-56% as volume surge forced product mix shift. Standalone EBITDA margin fell from 21% to 19.9%.
Antolin integration status
NeutralOn track operationally and financially. Finance costs ₹234M Q2 depressing consolidated PAT, but management reaffirms temporary nature and integration synergy capture.
Capex outlook
NeutralManagement refuses numeric capex guidance, says 'keeps changing with every discussion.' No shift from prior call, same hedge position.
Long-term portfolio positioning
NeutralReaffirmed >35% powertrain agnostic revenue, ~60% business insulated from powertrain shifts. New order pipeline ₹1,000+ Cr visible. No change from prior narrative.
The Q&A
Analysts pressed hard on gross margin recovery timeline, capex numbers, and order win details. Management held firm on not quantifying capex ('misleading if we do') and order wins ('competitive sensitivity'). Candid on commodity lag mechanics and wage cost impact, but defensive overall.
Capex plans — Vivek, DSP Mutual Fund
DodgedCapex expanding in Pithampur, Pathredi, Ghaziabad, Neemrana precision molding, TGPEL, interiors. Size 'very sizable' but no numbers given; keeps changing with decisions.
Headliner adoption — Radha, Motilal Oswal
AnsweredSmall cars 15%-18% cost improvement, bigger vehicles up to 30%-40%. Nominated by customers for EV programs. Two-three customers in proof-of-concept phase.
Piston growth sustainability — Radha, Motilal Oswal
AnsweredYes, maintained 17% H1 standalone growth. Market growing 7%-8%, we outgrowing. Next 2 years taper to 7%-8% CAGR as base normalizes.
Incremental growth source — Ravi Purohit, Securities Investment Management
AnsweredNew order wins between ₹1,000 crores easil above existing ₹6,000 crores business. Lighting, Antolin complete assembly wins, non-auto. Growth could be 9%-14% depending on mix.
Gross margin decline attribution — Harsh Shah, Seven Rivers Holdings
PartialComplex: mix 4%-5% impact, time lag ~1 quarter. Recovery formula depends on customer, varies. Whole recovery based on respective raw material.
Standalone EBITDA normalization — Harsh Shah, Seven Rivers Holdings
AnsweredNo. Core EBITDA margin 19.9% in Q2, almost 20%, best in industry. 1%-2% drop from mix, most costs getting covered, can improve costs.
Defense/aerospace adjacency — Harsh Shah, HRS Enterprises
AnsweredDefense good possibility (Shaktiman, Avadi). Aerospace long gestation (3-5 years), requires NadCap, tests. Focused on defense Army applications, already supply multiple defense products.
Acquisition targets — Harsh Shah, HRS Enterprises
PartialClarified thermal mgmt was media misquote. Looking at parallel adjacencies specific to vehicle industry. Not direct entry into these, but adjacent areas.
Lighting revenue contribution — Vijay Pandey, Axis Capital
AnsweredGrowing at very good rate. Won excellent new programs. At acquisition ~20% of interiors business, growing much faster than interiors now.
RM basket composition Q3 — Vijay Pandey, Axis Capital
PartialVery difficult to quantify, month-to-month variations. Depends on sales mix. Aluminum ~50%, steel/copper ~20%-25%. All depends on kind of mix and supplies.
Guidance
Grow with market 7%-8% as base normalizes post-FY27
MediumFY27 is high-growth year due to Antolin acquisition, volume ramp, new wins. Thereafter normalize to market CAGR. Piston segment ~10%-12% for 2-3 years, then 7%-8% CAGR.
Margin normalization expected Q3 FY27
MediumCommodity pass-through lag to unwind as Q3 covers commodity inflation spike. Gross margins expected to improve from 55%-56% back toward 58%-60%. Standalone EBITDA margin target ~20% (vs 19.9% Q2).
Antolin to reach mid-teens EBITDA margins long-term
MediumCurrently depressed due to finance costs ₹234M Q2 from acquisition debt. Post-debt repayment, margins to normalize toward 15%+ as scale benefits accrue.
Capex ongoing across all segments, size 'very sizable'
LowManagement deliberately avoids quantifying, says capex plan changes with every strategic decision. Backed by firm orders. Most expansions phased (Pithampur, Pathredi, Ghaziabad, Neemrana).
Risks the call surfaced
Commodity & geopolitical
High1-quarter pass-through lag leaves gross margins compressed 400+ bps. Oil, tools, dyes elevated due to Russia-Ukraine and Middle East tensions. Recovery dependent on supply chain normalization.
Margin volatility
HighOperating at 75%-80% capacity. Market volume surge to 30%-35% forced product mix shift to preserve market share, compressing gross margins 400+ bps. Q3 recovery dependent on commodity lag pass-through, not mix normalization.
Wage cost & regulation
MediumMinimum Wages Act revisions in Haryana, UP, Rajasthan. PF and gratuity regulation changes creating new cost floor. Large workforce makes this a 'sizable amount' impact.
Antolin integration & finance cost
MediumFinance costs ₹234M Q2, ₹486M H1 from Antolin acquisition debt financing. Temporary but material drag on consolidated PAT. Integration execution risk remains.
Customer concentration & order detail risk
MediumManagement refuses to name customers or detail order wins, citing competitive sensitivity. Suggests concentration risk and limits transparency.
Capex execution & guidance
MediumManagement refuses to quantify capex, says 'keeps changing with every discussion.' Suggests execution uncertainty and strategic flexibility, but also raises visibility risk.
Management
Score 6/10. Candid on challenges (commodity lag, wage pressures, integration costs) and detailed on business mechanics (mix impact, pass-through lag). Evasive on capex numbers and order win specifics, citing competitive sensitivity. Hit topline growth targets (~62% YoY vs 61% claimed). Accurately explained margin compression via commodity lag and mix shift. Antolin integration on track operationally. Track record credible on acknowledged headwinds.
1 · Q3 FY27
Commodity pass-through lag unwinds, margin normalization expected
2 · Apr 2027
Precision plastics ABS product supplies begin for 2-wheeler regulators
3 · FY28
EMFI and Takahata capacity expansions begin revenue contribution
Hold pending Q3 margin recovery validation and clearer forward quantification.
Informational and educational content only. Not investment advice.